Eloxx Pharmaceuticals ELOX
NASDAQ ELOX
$13.00 -0.20 (-1.52%)
As of: Oct 22, 2026 · 10:40 AM EDT

Eloxx Pharmaceuticals (ELOX) Notes Payables (2016 - 2017)

Updated

Eloxx Pharmaceuticals' Notes Payables was $407,122 in FY2017.

Analysis

Eloxx Pharmaceuticals (ELOX) Notes Payables (2016 - 2017) Analysis & Trends

  • Per Business Quant data, Notes Payables in earlier years was $300,000 in FY2016.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,166.78 Bn 1,135.37 Bn 19.71 Bn
2 Johnson & Johnson 635.34 Bn 553.86 Bn 17.26 Bn
3 AbbVie 503.48 Bn 476.60 Bn 12.70 Bn
4 Merck 377.08 Bn 331.46 Bn 12.21 Bn
5 Novartis Ag 304.13 Bn 268.12 Bn 11.24 Bn
6 Astrazeneca 267.48 Bn 241.16 Bn 12.86 Bn
7 Amgen 241.75 Bn 197.15 Bn 7.24 Bn
8 Gilead Sciences 194.09 Bn 168.29 Bn 6.22 Bn
9 Pfizer 172.59 Bn 119.24 Bn 10.94 Bn
10 Eloxx Pharmaceuticals 88.26 Mn 14.58 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2017 712,335.00
Jun 30, 2017 407,122.00
Mar 31, 2017 256,819.00
Dec 31, 2016 300,000.00
API Access

Eloxx Pharmaceuticals Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=ELOX&period=max&api_key=YOUR_API_KEY